Abstract
Licensed human papillomavirus (HPV) vaccines, based on virus-like particles (VLP) self-assembled from major capsid protein L1, afford type-restricted protection against types 16/18/6/11 (or 16/18 for the bivalent vaccine), which cause...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have